EUCTR2004-002795-42-IT进行中（未招募）不适用
SHEPHERD: Safety in hemolytic PNH patients treated with Eculizumab: a multi-center open label research design study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 85
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Safety in Hemolytic PNH Patients Treated with Eculizumab: A Multi-center Open-label Research Design Study - SHEPHERDEUCTR2004-002795-42-IEALEXION PHARMACEUTICALS INCORPORATED97
进行中（未招募）
1 期
Safety in Hemolytic PNH Patients Treated with Eculizumab: A Multi-center Open-label Research Design Study - SHEPHERDparoxysmal nocturnal hemoglobinuriaMedDRA version: 7.0Level: PTClassification code 10034042EUCTR2004-002795-42-ESALEXION PHARMACEUTICALS INCORPORATED97
进行中（未招募）
1 期
Safety in Hemolytic PNH Patients Treated with Eculizumab: A Multi-center Open-label Research Design Study - SHEPHERDparoxysmal nocturnal hemoglobinuriaMedDRA version: 7.0Level: PTClassification code 10034042EUCTR2004-002795-42-GBALEXION PHARMACEUTICALS INCORPORATED97
进行中（未招募）
不适用
Safety in Hemolytic PNH Patients Treated with Eculizumab: A Multi-center Open-label Research Design Study - SHEPHERDparoxysmal nocturnal hemoglobinuriaMedDRA version: 7.0Level: PTClassification code 10034042EUCTR2004-002795-42-SEALEXION PHARMACEUTICALS INCORPORATED85
进行中（未招募）
不适用
Safety in Hemolytic PNH Patients Treated with Eculizumab: A Multi-center Open-label Research Design Study - SHEPHERDEUCTR2004-002795-42-DEALEXION PHARMACEUTICALS INCORPORATED85